Saurabh Saha, CEO of Centessa Pharmaceuticals plc ($CNTA), sold about $3.9 million in company shares through six open market transactions over the past year. His most recent sale occurred on July 21, 2025. These sales rank 2,290th among 11,678 insiders in our database, where the average is $8.6 million across roughly 6.4 transactions per person. Saha made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 21, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Ordinary Shares | 55000 | $3.85 | 314,017.0000 | 133,184,349 | 21.23% | 0.04% |
| July 21, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Share Option (right to buy) | 55000 | $0.00 | 150,000.0000 | 133,184,349 | 26.83% | 0.04% |
| July 21, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 55000 | $15.92 | 259,017.0000 | 133,184,349 | 17.51% | 0.04% |
| June 20, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Share Option (right to buy) | 55000 | $0.00 | 205,000.0000 | 133,184,349 | 21.15% | 0.04% |
| June 20, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 55000 | $12.63 | 259,017.0000 | 133,184,349 | 17.51% | 0.04% |
| June 20, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Ordinary Shares | 55000 | $3.85 | 314,017.0000 | 133,184,349 | 21.23% | 0.04% |
| May 20, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Share Option (right to buy) | 55000 | $0.00 | 260,000.0000 | 133,184,349 | 17.46% | 0.04% |
| May 20, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Ordinary Shares | 55000 | $3.85 | 314,017.0000 | 133,184,349 | 21.23% | 0.04% |
| May 20, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 55000 | $12.71 | 259,017.0000 | 133,184,349 | 17.51% | 0.04% |
| May 6, 2025 | CLARIVATE PLC | $CLVT | SAHA SAURABH | Director | F | Ordinary Shares | 4974 | $4.17 | 77,042.0000 | 693,600,000 | 6.06% | 0.00% |
| May 7, 2025 | CLARIVATE PLC | $CLVT | SAHA SAURABH | Director | A | Ordinary Shares | 39473 | $0.00 | 116,515.0000 | 693,600,000 | 51.24% | 0.01% |
| April 21, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 14656 | $12.29 | 299,361.0000 | 133,184,349 | 4.67% | 0.01% |
| April 22, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 40344 | $12.43 | 259,017.0000 | 133,184,349 | 13.48% | 0.03% |
| March 20, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 55000 | $16.69 | 314,017.0000 | 133,184,349 | 14.90% | 0.04% |
| March 3, 2025 | CLARIVATE PLC | $CLVT | SAHA SAURABH | Director | P | Ordinary Shares | 58275 | $4.36 | 82,016.0000 | 693,600,000 | 245.46% | 0.01% |
| Feb. 20, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 54225 | $15.92 | 369,792.0000 | 0 | 12.79% | 0.00% |
| Feb. 20, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 775 | $16.54 | 369,017.0000 | 0 | 0.21% | 0.00% |
| Feb. 3, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | A | Share Option (right to buy) | 900000 | $0.00 | 900,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | F | Ordinary Shares | 43381 | $16.92 | 424,017.0000 | 0 | 9.28% | 0.00% |
| Jan. 21, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 53375 | $15.76 | 469,023.0000 | 0 | 10.22% | 0.00% |
| Jan. 21, 2025 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 1625 | $16.19 | 467,398.0000 | 0 | 0.35% | 0.00% |
| Dec. 31, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | F | Ordinary Shares | 36263 | $16.35 | 522,398.0000 | 0 | 6.49% | 0.00% |
| Dec. 20, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 55000 | $17.44 | 558,661.0000 | 0 | 8.96% | 0.00% |
| Dec. 6, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Share Option (right to buy) | 87496 | $0.00 | 3,869,485.0000 | 0 | 2.21% | 0.00% |
| Dec. 6, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Ordinary Shares | 87496 | $5.84 | 701,157.0000 | 0 | 14.26% | 0.00% |
| Dec. 6, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 87496 | $18.46 | 613,661.0000 | 0 | 12.48% | 0.00% |
| Nov. 25, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Ordinary Shares | 299 | $5.84 | 613,960.0000 | 0 | 0.05% | 0.00% |
| Nov. 25, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 299 | $18.23 | 613,661.0000 | 0 | 0.05% | 0.00% |
| Nov. 25, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Share Option (right to buy) | 299 | $0.00 | 3,956,981.0000 | 0 | 0.01% | 0.00% |
| Nov. 21, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Ordinary Shares | 3511 | $5.84 | 617,172.0000 | 0 | 0.57% | 0.00% |
| Nov. 20, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 55000 | $16.89 | 613,661.0000 | 0 | 8.23% | 0.00% |
| Nov. 21, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 3511 | $18.24 | 613,661.0000 | 0 | 0.57% | 0.00% |
| Nov. 22, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Ordinary Shares | 1671 | $5.84 | 615,332.0000 | 0 | 0.27% | 0.00% |
| Nov. 22, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 1671 | $18.24 | 613,661.0000 | 0 | 0.27% | 0.00% |
| Nov. 21, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Share Option (right to buy) | 3511 | $0.00 | 3,958,951.0000 | 0 | 0.09% | 0.00% |
| Nov. 22, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Share Option (right to buy) | 1671 | $0.00 | 3,957,280.0000 | 0 | 0.04% | 0.00% |
| Nov. 13, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Ordinary Shares | 32023 | $5.84 | 700,684.0000 | 0 | 4.79% | 0.00% |
| Nov. 13, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Share Option (right to buy) | 32023 | $0.00 | 3,962,462.0000 | 0 | 0.80% | 0.00% |
| Nov. 13, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 32023 | $18.28 | 668,661.0000 | 0 | 4.57% | 0.00% |
| Oct. 22, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 30203 | $15.67 | 671,253.0000 | 0 | 4.31% | 0.00% |
| Oct. 21, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 22205 | $15.80 | 701,456.0000 | 0 | 3.07% | 0.00% |
| Oct. 23, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 2592 | $15.32 | 668,661.0000 | 0 | 0.39% | 0.00% |
| Sept. 30, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | F | Ordinary Shares | 36263 | $15.79 | 723,661.0000 | 0 | 4.77% | 0.00% |
| Sept. 20, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 55000 | $16.53 | 759,924.0000 | 0 | 6.75% | 0.00% |
| Sept. 10, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Ordinary Shares | 175000 | $5.84 | 989,924.0000 | 0 | 21.47% | 0.00% |
| Sept. 10, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | M | Share Option (right to buy) | 175000 | $0.00 | 3,994,485.0000 | 0 | 4.20% | 0.00% |
| Sept. 10, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 175000 | $16.52 | 814,924.0000 | 0 | 17.68% | 0.00% |
| Aug. 30, 2024 | CLARIVATE PLC | $CLVT | SAHA SAURABH | Director | S | Ordinary Shares | 17646 | $6.75 | 23,741.0000 | 671,600,000 | 42.64% | 0.00% |
| Aug. 23, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 46651 | $12.30 | 814,924.0000 | 0 | 5.41% | 0.00% |
| Aug. 20, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 4169 | $12.32 | 865,755.0000 | 0 | 0.48% | 0.00% |
| Aug. 21, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 3674 | $12.25 | 862,081.0000 | 0 | 0.42% | 0.00% |
| Aug. 22, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | S | Ordinary Shares | 506 | $12.23 | 861,575.0000 | 0 | 0.06% | 0.00% |
| June 30, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | F | Ordinary Shares | 36263 | $9.03 | 869,924.0000 | 0 | 4.00% | 0.00% |
| May 7, 2024 | CLARIVATE PLC | $CLVT | SAHA SAURABH | Director | A | Ordinary Shares | 23741 | $0.00 | 41,387.0000 | 671,600,000 | 134.54% | 0.00% |
| May 6, 2024 | CLARIVATE PLC | $CLVT | SAHA SAURABH | Director | F | Ordinary Shares | 4412 | $7.05 | 17,646.0000 | 671,600,000 | 20.00% | 0.00% |
| March 31, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | F | Ordinary Shares | 36263 | $11.30 | 906,187.0000 | 0 | 3.85% | 0.00% |
| Feb. 1, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | A | Ordinary Shares | 144200 | $0.00 | 968,773.0000 | 0 | 17.49% | 0.00% |
| Feb. 1, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | F | Ordinary Shares | 26323 | $8.19 | 942,450.0000 | 0 | 2.72% | 0.00% |
| Feb. 1, 2024 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | A | Share Option (right to buy) | 576800 | $0.00 | 576,800.0000 | 0 | 9999.99% | 0.00% |
| Dec. 31, 2023 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | F | Ordinary Shares | 36263 | $7.96 | 824,573.0000 | 0 | 4.21% | 0.00% |
| Sept. 30, 2023 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | F | Ordinary Shares | 36263 | $6.47 | 860,836.0000 | 0 | 4.04% | 0.00% |
| June 30, 2023 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | F | Ordinary Shares | 36263 | $5.90 | 897,099.0000 | 0 | 3.89% | 0.00% |
| May 4, 2023 | CLARIVATE PLC | $CLVT | SAHA SAURABH | Director | A | Ordinary Shares | 22058 | $0.00 | 22,058.0000 | 676,100,000 | 9999.99% | 0.00% |
| March 31, 2023 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | F | Ordinary Shares | 22013 | $3.90 | 933,362.0000 | 0 | 2.30% | 0.00% |
| Feb. 1, 2023 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | A | Ordinary Shares | 211400 | $0.00 | 955,375.0000 | 0 | 28.41% | 0.00% |
| Feb. 1, 2023 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | A | Share Option (right to buy) | 315000 | $0.00 | 315,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 31, 2022 | Centessa Pharmaceuticals plc | $CNTA | SAHA SAURABH | Chief Executive Officer | F | Ordinary Shares | 44025 | $3.10 | 743,975.0000 | 0 | 5.59% | 0.00% |